Montalbo, Rhea .
HRN: 19-24-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
MUPIROCIN 2%, 15G (TUBE)
04/10/2025
04/16/2025
TOPICAL
2%
BID
Post Extraction Site Hematoma
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes